Future directions in CTC research aim to improve detection technologies, enhance our understanding of CTC biology, and translate findings into clinical applications. Advances in microfluidics and nanotechnology are expected to enhance the sensitivity and specificity of CTC detection methods. Furthermore, integrating genomic and proteomic analyses with CTC studies will provide deeper insights into the molecular mechanisms driving cancer metastasis. Ultimately, the goal is to develop personalized treatment strategies and improve patient outcomes by leveraging the knowledge gained from CTC research.
